| Literature DB >> 26317030 |
Huidrom Suraj Singh1, Kabita Salam2, Kallur Nava Saraswathy3.
Abstract
Chronic alcohol consumption is reported to be associated with increase in plasma homocysteine levels which is further influenced by the polymorphism in methylenetetrahydrofolate reductase (MTHFR) gene. The present study aims to understand the extent of the MTHFR C677T polymorphism in alcohol dependent (AD) cases of Meiteis of Manipur, a Mendelian population of India. MTHFR C677T polymorphism was screened in 313 controls and 139 alcohol dependent (AD) cases who all met DSM-IV criteria for alcohol dependence. Both AD cases and controls were unrelated up to 1st cousin. Among the control group, different drinking patterns like abstainer/nondrinkers (NDs), occasional drinkers (ODs), and moderate drinkers (MDs) are included. Both the groups were found to be in Hardy-Weinberg equilibrium (P > 0.05). Genotypic and allelic frequency distribution of MTHFR C677T polymorphism did not differ significantly between AD cases and controls (P > 0.05). However, individuals carrying mutant (T) allele show more than 1-fold increased risk for AD though not significant (OR = 1.43; 95% CI 0.41-5.01, P > 0.05). In conclusion, MTHFR C677T polymorphism is not found to be risk marker for AD in present studied population. However, higher prevalence of the mutant T allele may exacerbate deleterious health risk in future especially among alcohol drinkers.Entities:
Year: 2014 PMID: 26317030 PMCID: PMC4437350 DOI: 10.1155/2014/310241
Source DB: PubMed Journal: J Biomark ISSN: 2090-7699
Characteristic feature of the selected SNP MTHFR C677T polymorphism.
| Gene | SNP (rs) | Position | Nucleotide sequence | Restriction enzyme | Reference |
|---|---|---|---|---|---|
|
| C677T (1801133) | Exon 4 | F5′TGAAGGAGAAGGTGTCTGCGGGA3′ |
|
Arruda et al., 1997 [ |
| R5′AGGACGGTGCGGTGAGAGTG3′ |
Genotypic and allelic frequency distribution of MTHFR C677T gene polymorphism among different patterns of alcohol consumption.
| Genetic Marker ( | AD cases ( | Controls (ND + OD + MD) ( |
ND ( |
OD ( |
MD ( |
| |||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| CC (%) | 91 (65.47) | 228 (72.84) | 89 (73.55) | 81 (71.68) | 58 (73.42) | 0.283 | 0.366 | 0.876 | 0.352 |
| CT (%) | 44 (31.65) | 78 (24.92) | 29 (23.97) | 28 (24.78) | 21 (26.58) | ||||
| TT (%) | 4 (2.88) | 7 (2.24) | 3 (2.48) | 4 (3.54) | 0 | ||||
|
| |||||||||
| C (frequency) | 226 (0.81) | 534 (0.85) | 207 (0.86) | 190 (0.84) | 137 (0.87) | 0.129 | 0.334 | 0.901 | 0.378 |
| T (frequency) | 52 (0.19) | 92 (0.15) | 38 (0.14) | 36 (0.16) | 21 (0.13) | ||||
N: number; ND: nondrinkers; OD: occasional drinkers; MD: moderate drinkers.
χ 2: likelihood ratio test comparing genotype and allele frequency; P 1 = AD versus control (ND + OD + MD); P 2 = AD versus ND; P 3 = ND versus OD; P 4 = ND versus MD; significance level at 5%.
Relative risk analysis (Odds Ratio) of MTHFR C677T polymorphism and different drinking patterns.
|
| AD | Control | ND | OD | MD | OR1 (95% CI) |
| OR2 (95% CI) |
| OR3 (95% CI) |
| OR4 (95% CI) |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CC | 91 | 228 | 89 | 81 | 58 | Reference | Reference | Reference | Reference | ||||
| CT | 44 | 78 | 29 | 28 | 21 | 1.41 (0.91–2.20) | 0.12 | 1.48 (0.85–2.58) | 0.16 | 1.06 (0.58–1.93) | 0.84 | 1.11 (0.58–2.13) | 0.75 |
| TT | 4 | 7 | 3 | 4 | 0 | 1.43 (0.41–5.01) | — | 1.30 (0.28–5.99) | — | 1.46 (0.32–6.74) | — | — | — |
| CT + TT | 48 | 85 | 32 | 32 | 21 | 1.41 (0.92–2.17) | 0.11 | 1.47 (0.86–2.50) | 0.16 | 1.10 (0.62–1.95) | 0.75 | 1.01 (0.53–1.91) | 1 |
ND: nondrinkers; OD: occasional drinkers; MD: moderate drinkers.
OR1: odd ration between AD and control; OR2: odd ration between AD and ND; OR3: odd ration between ND and OD; OR4: odd ration between ND and MD; CI: confidential interval.
P 1 = AD versus control (ND + OD + MD); P 2 = AD versus ND; P 3 = ND versus OD; P 4 = ND versus MD; significance level at 5%.